Anti-Infective Drugs Advisory Committee
Committee Meeting on April 5, 2011, from 8:30 a.m. to 4:00 p.m.
Agenda: On April 5, 2011, the committee will discuss new drug application (NDA) 20-1699, for FIDAXOMICIN tablets, submitted by Optimer Pharmaceuticals, Inc., for the requested indication of treatment of adults with Clostridium difficile infection (CDI), also known as Clostridium difficile-associated diarrhea (CDAD), and prevention of recurrences.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment